Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
The FLRT3-UNC5B checkpoint pathway inhibits T cell-based cancer immunotherapies.
Sci Adv. 2024 Mar;10(9):eadj4698. doi: 10.1126/sciadv.adj4698. Epub 2024 Mar 1.
Sci Adv. 2024.
PMID: 38427724
Free PMC article.
LAIR-1 agonism as a therapy for acute myeloid leukemia.
Lovewell RR, Hong J, Kundu S, Fielder CM, Hu Q, Kim KW, Ramsey HE, Gorska AE, Fuller LS, Tian L, Kothari P, Paucarmayta A, Mason EF, Meza I, Manzanarez Y, Bosiacki J, Maloveste K, Mitchell N, Barbu EA, Morawski A, Maloveste S, Cusumano Z, Patel SJ, Savona MR, Langermann S, Myint H, Flies DB, Kim TK.
Lovewell RR, et al. Among authors: bosiacki j.
J Clin Invest. 2023 Nov 15;133(22):e169519. doi: 10.1172/JCI169519.
J Clin Invest. 2023.
PMID: 37966113
Free PMC article.
Item in Clipboard
Cancer immunotherapy by NC410, a LAIR-2 Fc protein blocking human LAIR-collagen interaction.
Ramos MIP, Tian L, de Ruiter EJ, Song C, Paucarmayta A, Singh A, Elshof E, Vijver SV, Shaik J, Bosiacki J, Cusumano Z, Jensen C, Willumsen N, Karsdal MA, Liu L, Langermann S, Willems S, Flies D, Meyaard L.
Ramos MIP, et al. Among authors: bosiacki j.
Elife. 2021 Jun 14;10:e62927. doi: 10.7554/eLife.62927.
Elife. 2021.
PMID: 34121658
Free PMC article.
Item in Clipboard
Cite
Cite